• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Mutation analysis of K-ras oncogenes in gastroenterologic cancers by the amplified created restriction sites method.

作者信息

Lin S Y, Chen P H, Wang C K, Liu J D, Siauw C P, Chen Y J, Yang M J, Liu M H, Chen T C, Chang J G

机构信息

Department of Molecular Medicine and Clinical Pathology, Taipei Municipal Jen-Ai Hospital, Taiwan, Republic of China.

出版信息

Am J Clin Pathol. 1993 Dec;100(6):686-9. doi: 10.1093/ajcp/100.6.686.

DOI:10.1093/ajcp/100.6.686
PMID:8249918
Abstract

A rapid, simple, and nonradioactive method for diagnosing point mutations of c-K-ras oncogenes in gastroenterologic cancers is described. This method involved the selective amplification of DNA fragments from cancer tissues of surgical specimens with specific oligonucleotide primers, followed by digestion with restriction enzymes that recognized artificially created or naturally occurring restriction sites. To detect codon 12 mutations, an artificial Msp I site was created by introducing a single nucleotide mismatch into the 5' mutagenesis primer. Using a similar approach, an Hae III site was created to detect codon 13 mutations. Bal I and MBo II sites were used to detect codon 61 mutations. A total of 61 gastroenterologic cancer cases were studied. Of 35 cases of colorectal cancer, 7 showed mutations: 6 at codon 12 and 1 at codon 13. In 1 of 2 cases of cholangiocellular carcinoma, point mutation at codon 12 was found. One case of duodenal cancer showed point mutation at codon 12. No mutations were found in the cases of hepatocellular carcinoma (4), gastric cancer (12), esophageal cancer (3), or pancreatic cancer (2).

摘要

相似文献

1
Mutation analysis of K-ras oncogenes in gastroenterologic cancers by the amplified created restriction sites method.
Am J Clin Pathol. 1993 Dec;100(6):686-9. doi: 10.1093/ajcp/100.6.686.
2
"Hot spots" mutation analysis of p53 gene in gastrointestinal cancers by amplification of naturally occurring and artificially created restriction sites.
Clin Chem. 1993 Oct;39(10):2186-91.
3
Rapid diagnosis of beta-thalassemia mutations in Chinese by naturally and amplified created restriction sites.利用自然产生和扩增产生的限制性酶切位点快速诊断中国人β-地中海贫血突变
Blood. 1992 Oct 15;80(8):2092-6.
4
Analysis of ras gene mutations in gastrointestinal cancers.
J Formos Med Assoc. 1991 Dec;90(12):1149-54.
5
Glycine to aspartic acid mutations at codon 13 of the c-Ki-ras gene in human gastrointestinal cancers.人类胃肠道癌症中c-Ki-ras基因第13密码子处甘氨酸到天冬氨酸的突变
Cancer Res. 1990 Feb 1;50(3):480-2.
6
Rapid detection of ras oncogenes in human tumors: applications to colon, esophageal, and gastric cancer.人类肿瘤中ras癌基因的快速检测:在结肠癌、食管癌和胃癌中的应用。
Oncogene. 1989 Jul;4(7):923-8.
7
Ras oncogene and p53 gene hotspot mutations in colorectal cancers.结直肠癌中的Ras癌基因和p53基因热点突变。
J Gastroenterol Hepatol. 1995 Mar-Apr;10(2):119-24. doi: 10.1111/j.1440-1746.1995.tb01064.x.
8
[Sensitive detection of K-ras oncogene codon 12 mutations by nested PCR using mismatched primers and selective digestion of non-mutated PCR fragments with restriction enzyme].[使用错配引物的巢式聚合酶链反应及用限制酶选择性消化非突变聚合酶链反应片段对K-ras癌基因密码子12突变进行灵敏检测]
Rinsho Byori. 1993 Sep;41(9):1017-23.
9
Rapid and sensitive nonradioactive detection of mutant K-ras genes via 'enriched' PCR amplification.通过“富集”聚合酶链反应扩增快速灵敏地非放射性检测突变型K-ras基因
Oncogene. 1991 Jun;6(6):1079-83.
10
Detection of K-ras mutations in pancreatic and hepatic neoplasms by non-isotopic mismatched polymerase chain reaction.采用非同位素错配聚合酶链反应检测胰腺和肝脏肿瘤中的K-ras突变
Oncogene. 1991 May;6(5):857-62.

引用本文的文献

1
Sprouty2 protein enhances the response to gefitinib through epidermal growth factor receptor in colon cancer cells. sprouty2 蛋白通过表皮生长因子受体增强结肠癌细胞对吉非替尼的反应。
Cancer Sci. 2010 Sep;101(9):2033-8. doi: 10.1111/j.1349-7006.2010.01637.x.
2
Fast simultaneous detection of K-RAS mutations in colorectal cancer.结直肠癌中K-RAS突变的快速同步检测
BMC Cancer. 2009 Jun 11;9:179. doi: 10.1186/1471-2407-9-179.
3
Epigenetics modulates the effect of chemotherapy on gastric cancer.
J Gastroenterol. 2006 Feb;41(2):180-1. doi: 10.1007/s00535-006-1776-3.
4
Analysis of TSG101 tumour susceptibility gene transcripts in cervical and endometrial cancers.子宫颈癌和子宫内膜癌中TSG101肿瘤易感性基因转录本的分析。
Br J Cancer. 1999 Feb;79(3-4):445-50. doi: 10.1038/sj.bjc.6690069.
5
K-ras oncogene mutations indicate malignancy in cystic tumors of the pancreas.K-ras癌基因突变表明胰腺囊性肿瘤具有恶性特征。
Ann Surg. 1998 Jul;228(1):79-86. doi: 10.1097/00000658-199807000-00012.
6
Absence of ras gene mutations in early gastric carcinomas.早期胃癌中ras基因突变的缺失。
Gut. 1995 Dec;37(6):758-62. doi: 10.1136/gut.37.6.758.
7
Mutations of the Ki-ras oncogene in carcinoma of the endometrium.子宫内膜癌中Ki-ras癌基因的突变
Am J Pathol. 1995 Jan;146(1):182-8.